Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

AG-ESCITALOPRAM TABLETS - Health Canada Drug Approval Details

Approvals/Health Canada/AG-ESCITALOPRAM TABLETS

Authorized

STANDARD

AG-ESCITALOPRAM TABLETS

angita pharma inc.🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: 5ccf1cf48d882b17
Company: angita pharma inc.
Type: Standard

Approval Details

Approval Id: 5ccf1cf48d882b17
Drug Approval Canada Name: AG-ESCITALOPRAM TABLETS
Product Name: AG-ESCITALOPRAM TABLETS
Status: Marketed
Status Date: 2025-04-16
Original Market Date: 2025-04-16
Din: 02510952
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:16.04.20
Atc Original: N06AB10 ESCITALOPRAM
Atc Name: n 06 ab 10
Aig Number: 0150435004
Company Name: angita pharma inc.
Company Address: 1310 Rue Nobel, Boucherville, Quebec, Canada, J4B 5H3

Active Ingredients

ESCITALOPRAM (ESCITALOPRAM OXALATE)

20 MG

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

5ccf1cf48d882b17

Type

Standard

Back to Health Canada Approvals